Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers clinical trial (NCT04886531). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to standard options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers clinical trial (NCT04886531). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers clinical trial (NCT04886531). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers clinical trial (NCT04886531). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers clinical trial (NCT04886531). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens after the trial is over?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers clinical trial (NCT04886531). Contact the study team or your healthcare provider for specific answers.

What this study is about